🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is to test the efficacy, safety and tolerability...
Status
Completed
Location
1218.6.3302A Boehringer Ingelheim Investigational Site
Start Date
2006-04
Trial ID
NCT00309608
Treatments Being Tested
The aim of the trial is to assess the relative bioavailability of fixed dos...
Status
Completed
Location
1288.5.86001 Boehringer Ingelheim Investigational Site
Start Date
2012-02
Trial ID
NCT01540487
Treatments Being Tested
Assessment of the effect of BI 1356 or Placebo on prolongation of the QT in...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT02183467
Treatments Being Tested
A phase III randomised, double-blind parallel group extension study to inve...
Status
Completed
Location
1218.52.11005 Boehringer Ingelheim Investigational Site
Start Date
2009-06
Trial ID
NCT00915772
Treatments Being Tested
The primary objective is to demonstrate superior glycaemic control (HbA1c r...
Status
Completed
Location
1264.3.01026 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01183013
Type 2 diabetes is a chronic disease that has reached global epidemic propo...
Status
Unknown
Location
Universidad de Guanajuato
Start Date
2019-09-01
Trial ID
NCT04134650
Treatments Being Tested
TQ-F3083 capsule is a new type inhibitor of DPP-IV, which is currently a ve...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical Uversity
Start Date
2020-01-01
Trial ID
NCT03986073
Two independent study parts (i.e. Part A and Part B) are included in this t...
Status
Completed
Location
Tokai Memorial Hospital
Start Date
2015-05-12
Trial ID
NCT02489968
Study to investigate the safety, tolerability, pharmacokinetics, and pharma...
Status
Completed
Location
Multiple Locations
Start Date
2005-08
Trial ID
NCT02183415
Treatments Being Tested
The primary objective of this trial is to establish the bioequivalence of t...
Status
Completed
Location
Humanpharmakologisches Zentrum Biberach
Start Date
2018-08-27
Trial ID
NCT03629054